1. Home
  2. OMAB vs RYTM Comparison

OMAB vs RYTM Comparison

Compare OMAB & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS

OMAB

Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS

HOLD

Current Price

$111.14

Market Cap

5.7B

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$85.65

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMAB
RYTM
Founded
1998
2008
Country
Mexico
United States
Employees
1326
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.8B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
OMAB
RYTM
Price
$111.14
$85.65
Analyst Decision
Buy
Strong Buy
Analyst Count
4
14
Target Price
$120.00
$131.14
AVG Volume (30 Days)
87.2K
669.5K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
3.70%
N/A
EPS Growth
N/A
28.34
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.36
$55.34
Revenue Next Year
$13.05
$86.06
P/E Ratio
$21.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$84.74
$55.31
52 Week High
$134.99
$122.20

Technical Indicators

Market Signals
Indicator
OMAB
RYTM
Relative Strength Index (RSI) 43.62 45.80
Support Level $110.22 $82.98
Resistance Level $114.48 $90.79
Average True Range (ATR) 3.14 3.46
MACD -0.07 0.21
Stochastic Oscillator 4.31 30.40

Price Performance

Historical Comparison
OMAB
RYTM

About OMAB Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS

Grupo Aeroportuario del Centro Norte SAB de CV operates airports in the central region of Mexico. The airport is in Monterrey, which serves nearly half of the company's total passengers. In addition, the company manages two hotels and one industrial park. Its reportable segments include its airports, the Terminal 2 NH Collection Hotel, the Hilton Garden Inn Hotel and the OMA-VYNMSA Industrial Park, individually, and information about its holding company and other companies is combined in the Others.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: